Emphasize Daily Adherence With the New Oral Anticoagulants After Cardioversion
December 2014
You'll see the new oral anticoagulants (Pradaxa, Xarelto, Eliquis) used in patients with new onset atrial fib undergoing cardioversion.
We know that cardioversion sometimes converts patients back to normal heart rhythm. But it increases the risk of stroke...if an atrial clot is dislodged during the procedure.
That's why anticoagulants are usually given for at least 3 weeks in therapeutic doses before cardioversion...to stabilize clots and decrease the risk of embolism.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote